Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II

Life Sciences

Volumn 75, Issue 21, 2004, Pages 2505-2513

  Liu, Ximing ^a   Wei, Junping ^a   Tan, Fengsen ^b   Zhou, Shengming ^c   Würthwein, Gudrun ^d   Rohdewald, Peter ^d  

^a Beijing   (China)

^b Liberation Army   (China)

^c Lai Wu Hosp of Xin Wen Mineral Bur   (China)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Diabetes; Endothelin 1; HbA1; Prostaglandin; Pycnogenol

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTIDIABETIC AGENT; CREATININE; ELECTROLYTE; ENDOTHELIN 1; GLUCOSE; HEMOGLOBIN A1C; NITRIC OXIDE; PYCNOGENOL; UREA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ENDOTHELIUM; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PINE; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STATISTICAL ANALYSIS; UREA NITROGEN BLOOD LEVEL;

6-KETOPROSTAGLANDIN F1 ALPHA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOTHELIN-1; FEMALE; FLAVONOIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHYTOTHERAPY; PINUS; PLANT EXTRACTS;

PINUS PINASTER;

EID: 4444377960     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.043     Document Type: Article

References (20)

1. D. Alonso, and M.W. Radonski The nitric oxide-endothelin-1 connection Heart Failure Reviews 8 2003 107 115
2. M. Araghi-Nicknam, S. Hosseini, D. Larson, P. Rohdewald, and R.R. Watson Pine bark extract reduces platelet aggregation Integrative Medicine 2 1999 73 77
3. J. Calles-Escandon, E. Garcia-Rubi, S. Mira, and A. Mortensen Type 2 diabetes: one disease, multiple cardiovascular risk factors Coronary Artery Disease 10 1999 23 30
4. M.E. Carr Diabetes mellitus, a hypercoagulable state Journal of Diabetes complications 15 2001 44 54
5. S. Devaraj, N. Kaul, F. Schönlau, P. Rohdewald, and I. Jialal Pycnogenol® supplementation increases antioxidant capacity and has a favourable effect on the lipid profile in humans Lipids 37 10 2002 931 934
6. A.C. Fernandez, R. Patino, and J. Ibarra Endothelin in hypertension and diabetes mellitus T.F. Luscher Endothelin in cardiovascular diseases 1995 Springer Berlin, Heidelberg, New York 157 170
7. D.F. Fitzpatrick, B. Bing, and P. Rohdewald Endothelium-dependent vascular effects of Pycnogenol Journal of Cardiovascular Pharmacology 32 1998 509 515
8. M. Gábor, E. Engi, and S. Sonkodi Die Kapillarwandresistenz und ihre Beeinflussung durch wasserlösliche Flavonderivate bei spontan hypertonischen Ratten Phlebologie 22 1993 178 182
9. M. Kawamura, H. Obgawara, and M. Naruse Increased plasma endothelin in NIDDM patients with retinopathy Diabetes Care 51 1992 1396 1397
10. R. Koch Comparative study of Venostasin and Pycnogenol® in chronic venous insufficiency Phytotherapy Research 16 2002 1 5
11. O. Laurenti, E.M. Vingolo, and G.B. Desideri Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes related organ damage Experimental Clinical Endocrinology Diabetes 105 Suppl 2 1997 40 42
12. A. Lermann, B.S. Edward, J.W. Hallet, D.M. Heublein, S.M. Sandberg, and J.C. Burnett Circulating and tissue endothelin immunoactivity in advanced atherosclerosis National English Journal of Medicine 325 1991 997 1001
13. X. Liu, H.-J. Zhou, and P. Rohdewald French maritime pine bark extract Pycnogenol® Lowers glucose dose dependently in patients with diabetes type II Diabetes Care 27 3 2004 839
14. A. Maritim, B.A. Dene, R.A. Sanders, and J.B. Watkins III Effects of Pycnogenol® treatment on oxidative stress in streptozotocin-induced diabetic rats Journal of Biochemical Molecular Toxicology 17 3 2003 193 199
15. F. Perfetto, R. Tarquini, and V. de Leonardis Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus Recenti Progressi Medicinali 88 1997 317 320
16. F. Perfetto, R. Tarquini, L. Tapparini, and B. Tarquini Influence of non-insulin dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis Journal of Diabetes Complications 12 1998 187 192
17. M. Pütter, K.H.M. Grotemeyer, and G. Würthwein Inhibition of smoking induced platelet aggregation by aspirin and Pycnogenol® Thrombosis Research 95 1999 155 161
18. P. Rohdewald A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse pharmacology International Journal of Clinical Pharmacology and Therapeutics 40 2002 158 168
19. F. Schoenlau, and P. Rohdewald Pycnogenol® for diabetic retinopathy International Ophthalmology 24 2002 161 171
20. T.-M. Zhang, C.-H. Han, Y.-W. Han, H. Gong, E.-Y. Zhang, and Y. Zhang Inhibitory effect of Pycnogenol® on generation of advanced glycation end-products in vitro Chinese Pharmacology Bulletin 19 4 2003 437 440